- Prevalence of thalassemia carriers in Egypt nearly 9%; among the highest rates worldwide
- Drugs to remove excess iron improve patients’ lives and survival rates
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety:
Tel: +202 22861000 – Press 1 for reporting an adverse event. Fax: 002 02 26031702. E-Mail: [email protected]
This site is intended for an audience in Egypt.